Patent Foramen Ovale Closure in Migraine

NCT06192173 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2024-01-09

No results posted yet for this study

Summary

The goal of this observational study is to retrospectively observe the effect of PFO closure and medication on migraine. The main questions it aims to answer are:

* Whether PFO closure is more effective in the treatment of migraine than traditional medical treatment
* What factors affect the effectiveness of migraine treatment ?

Participants will undergo contrast transthoracic echocardiography to diagnose PFO and evaluate right-to-left shunt. They will be treated with medication and PFO closure respectively according to guidelines. HIT-6 and a questionnaire about migraine were obtained at the baseline and repeated at the 6-month and 12-month follow-up visits.

Researchers will compare closure group and drug group to see efficacy of two groups in treating migraine.

Conditions

Interventions

PROCEDURE

Percutaneous PFO closure

Two kinds of interventional closure methods including DSA-guided and TEE-guided percutaneous intervention were performed on closure group.

Sponsors & Collaborators

  • Haiyan Wang

    lead OTHER

Principal Investigators

  • Haiyan Wang · Shandong First Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-05
Primary Completion
2022-12-20
Completion
2023-05-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06192173 on ClinicalTrials.gov